Sterling Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.84K Sell
524
-105
-17% -$1.57K ﹤0.01% 2278
2025
Q1
$10.1K Sell
629
-380
-38% -$6.13K ﹤0.01% 1858
2024
Q4
$23.5K Buy
1,009
+894
+777% +$20.8K ﹤0.01% 1822
2024
Q3
$3.38K Buy
+115
New +$3.38K ﹤0.01% 1932